[免疫抑制药物治疗进行性系统性硬化症患者的生存时间]。

IF 0.5 Q4 DERMATOLOGY

Przeglad dermatologiczny Pub Date : 1989-09-01

Z Olszewska

{"title":"[免疫抑制药物治疗进行性系统性硬化症患者的生存时间]。","authors":"Z Olszewska","doi":"","DOIUrl":null,"url":null,"abstract":"A retrospective analysis of survival time was carried out in 29 progressive systemic sclerosis patients treated with immunosuppressive drugs and in 15 patients who underwent another mode of treatment. It was found that fatality in both groups studied was the same (case fatality rate approximately 35%), but the mean survival time of those who had died was much longer for 10 patients treated with immunosuppressive drugs than for the 5 patients who had not undergone this mode of treatment (p less than 0.05). The cumulative survival rate evaluated at 5 years from the beginning of treatment was also higher in patients treated with immunosuppressive drugs (79.3%) than in the other group under investigation (66.7%). However the difference between these results was not statistically significant.","PeriodicalId":20732,"journal":{"name":"Przeglad dermatologiczny","volume":"76 5-6","pages":"430-4"},"PeriodicalIF":0.5000,"publicationDate":"1989-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Survival time of progressive systemic sclerosis patients treated with immunosuppressive drugs].\",\"authors\":\"Z Olszewska\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"A retrospective analysis of survival time was carried out in 29 progressive systemic sclerosis patients treated with immunosuppressive drugs and in 15 patients who underwent another mode of treatment. It was found that fatality in both groups studied was the same (case fatality rate approximately 35%), but the mean survival time of those who had died was much longer for 10 patients treated with immunosuppressive drugs than for the 5 patients who had not undergone this mode of treatment (p less than 0.05). The cumulative survival rate evaluated at 5 years from the beginning of treatment was also higher in patients treated with immunosuppressive drugs (79.3%) than in the other group under investigation (66.7%). However the difference between these results was not statistically significant.\",\"PeriodicalId\":20732,\"journal\":{\"name\":\"Przeglad dermatologiczny\",\"volume\":\"76 5-6\",\"pages\":\"430-4\"},\"PeriodicalIF\":0.5000,\"publicationDate\":\"1989-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Przeglad dermatologiczny\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Przeglad dermatologiczny","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"DERMATOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

回顾性分析了29例接受免疫抑制药物治疗的进行性系统性硬化症患者和15例接受另一种治疗方式的患者的生存时间。结果发现，两组患者的病死率相同(病死率约为35%)，但接受免疫抑制药物治疗的10例患者的平均生存时间远长于未接受这种治疗的5例患者(p < 0.05)。接受免疫抑制药物治疗的患者在治疗开始后5年的累积生存率(79.3%)也高于另一组(66.7%)。然而，这些结果之间的差异没有统计学意义。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[Survival time of progressive systemic sclerosis patients treated with immunosuppressive drugs].

A retrospective analysis of survival time was carried out in 29 progressive systemic sclerosis patients treated with immunosuppressive drugs and in 15 patients who underwent another mode of treatment. It was found that fatality in both groups studied was the same (case fatality rate approximately 35%), but the mean survival time of those who had died was much longer for 10 patients treated with immunosuppressive drugs than for the 5 patients who had not undergone this mode of treatment (p less than 0.05). The cumulative survival rate evaluated at 5 years from the beginning of treatment was also higher in patients treated with immunosuppressive drugs (79.3%) than in the other group under investigation (66.7%). However the difference between these results was not statistically significant.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Przeglad dermatologiczny DERMATOLOGY-

CiteScore

0.80

自引率

14.30%

发文量

审稿时长

12 weeks

期刊介绍： Przegląd Dermatologiczny (ang. Dermatological Review) is a bimonthly magazine of the Polish Dermatological Association. It publishes original (clinical and experimental) papers, review papers, care reports, reports from congresses, reviews of books, announcements, letters to the editor and special papers (requested by the editors), concerning selected dermatological and interdisciplinary issues. Papers sent to the editor are reviewed.